H Schuitemaker

发表

The effect of plasma drug concentrations on HIV‐1 clearance rate during quadruple drug therapy

J W Mulder, H. Schuitemaker, J. Beijnen, 1998, AIDS.

Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain

H. Schuitemaker, R. Fouchier, A. Andeweg, 1992, Journal of virology.

Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.

H. Schuitemaker, A. M. de Roda Husman, J. Goudsmit, 1998, The Journal of infectious diseases.

Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR

H. Schuitemaker, R. Fouchier, M. Brouwer, 1995, Journal of clinical microbiology.

Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

Kees, H. Schuitemaker, N. Kootstra, 1994, The Journal of clinical investigation.

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.

C H Fox, H. Schuitemaker, C. Fox, 1999, AIDS.

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

H. Schuitemaker, N. Kootstra, J. Lange, 1992, Journal of virology.

Alternative multidrug regimen provides improved suppression of HIV‐1 replication over triple therapy

H. Schuitemaker, G. Weverling, F. de Wolf, 1998, AIDS.

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

H. Schuitemaker, N. Kootstra, R. Fouchier, 1992, Journal of virology.